Jason Drew Smith Insider Profile

4 Followers
Jason Drew Smith, GC at Urogen Pharma, holds 25.23K shares in Urogen Pharma (Ticker: URGN).
tipranks
Jason Drew Smith

Jason Drew Smith
Urogen Pharma (URGN)
GC

Not Ranked
Jason Drew Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$323K
100.00%
A breakdown of Jason Drew Smith's holdings

Insider Roles

Urogen Pharma
(URGN)
GC
Roles that Jason Drew Smith holds in companies

Most Profitable Insider Trade

Stock:
Urogen Pharma
(URGN)
Rating:Informative Buy
Date:May 18, 2021 - May 18, 2022
Return:-68.60%
The most profitable trade made by Jason Drew Smith

Jason Drew Smith's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Urogen Pharma
Sep 12, 2024
GC
Uninformative Buy
23.70K
$322.64K
Success Rate for
URGN
0 out of 1 profitable transactions on
URGN
0%
Average Return for
URGN
Average return per transaction on
URGN
-68.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
May 18, 2021
Informative Buy
$39.27K
-
$15.71
-68.60%
Dec 02, 2021
Uninformative Buy
$54.50K
-
$12.03
Feb 02, 2022
Uninformative Buy
$3.18K
-
$7.58
Sep 02, 2022
Uninformative Buy
$34.08K
-
$7.21
Feb 02, 2023
Uninformative Buy
$17.63K
-
$10.30
List of latest transactions for each holding click on a transaction to see Jason Drew Smith's performance on stock

Jason Drew Smith insider profile FAQ

What is the percentage of profitable transactions made by Jason Drew Smith?
The percentage of profitable transactions made by Jason Drew Smith is ―.
    What is the average return per transaction made by Jason Drew Smith?
    The average return per transaction made by Jason Drew Smith is ―.
      What stocks does Jason Drew Smith hold?
      Jason Drew Smith holds: URGN stocks.
        What was Jason Drew Smith’s latest transaction?
        Jason Drew Smith latest transaction was an Uninformative Buy of $23.70K.
          What was Jason Drew Smith's most profitable transaction?
          Jason Drew Smith’s most profitable transaction was an Informative Buy of URGN stock on May 18, 2021. The return on the trade was -68.60%.
            What is Jason Drew Smith's role in Urogen Pharma?
            Jason Drew Smith's role in Urogen Pharma is GC.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.